Benefit for a 6th-grader with Hodgkin's
Sixth-grader Rachelle Patterson has been battling late-stage Hodgkin's lymphoma for the past two months.
Several volunteers in her Indiana community have organized a fundraiser for 12 year old Rachelle. The event, called "Rallying 'Round Rachelle," will begin at 6 p.m. Nov. 11 at the Primo Banquet Hall on Hadley Road, east of Ind. 267 in Plainfield. It will feature musical performances by acts including Tecumseh Flyers, Stockwell Road, Danny Thompson and the Messarounds, and Creepin' Charley. The four acts play a broad range of styles, from roots rock to country folk.
In addition, there will be a silent auction throughout the evening, with a variety of items, including Colts tickets, airline tickets and autographed sports memorabilia.
Admission is $5 per person, with tickets available at the door. All proceeds will go to Rachelle's family.
Donations also may be mailed to Bank One, 807 Southfield Drive, Plainfield, IN 46168, made payable to "Rallying 'Round Rachelle." (From the IndyStar)
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
